SEC Form D · filed December 30, 2022
Palvella Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
George H. Jenkins · Wayne, PADirectorWesley H. Kaupinen · Wayne, PAExec · DirectorKathleen S. Mcgowan · Wayne, PAExecKathleen S. Goin · Wayne, PAExecTodd H. Davis · Wayne, PADirectorScott H. Morenstein · Wayne, PADirectorTadd S. Wessel · Wayne, PADirectorWilliam H. Koster · Boston, MADirectorMatt Ross · New York, NYExecAntonios T. Valamontes · Largo, FLExec · DirectorEric D. Chin · San Carlos, CADirectorTom Broussard · Boston, MADirectorDavid S. Edwards · Boston, MAExecAditya H. Asokan · Wayne, PADirectorJeffrey S. Martini · Wayne, PAExecMichael Konnert · VANCOUVER, British Columbia, CanadaExec · DirectorAlan Hartman · Redwood City, CADirectorMichael Kaplan · Redwood City, CADirectorDavid Krane · Mountain View, CAExecWilliam B. Bissett · Charlotte, NCExecKristoffer E. Bertagnolli · Idaho Falls, IDDirectorAditya H. Asokan · Wayne, PADirectorJeffrey S. Martini · Wayne, PAExecTadd S. Wessel · Wayne, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗